Cargando…
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study
Pre-symptomatic screening of genetic alterations might help identify subpopulations of individuals that could enter into early access prevention programs. Since liquid biopsy is minimally invasive it can be used for longitudinal studies in healthy volunteers to monitor events of progression from nor...
Autores principales: | Alborelli, Ilaria, Generali, Daniele, Jermann, Philip, Cappelletti, Maria Rosa, Ferrero, Giuseppina, Scaggiante, Bruna, Bortul, Marina, Zanconati, Fabrizio, Nicolet, Stefan, Haegele, Jasmin, Bubendorf, Lukas, Aceto, Nicola, Scaltriti, Maurizio, Mucci, Giuseppe, Quagliata, Luca, Novelli, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624284/ https://www.ncbi.nlm.nih.gov/pubmed/31296838 http://dx.doi.org/10.1038/s41419-019-1770-3 |
Ejemplares similares
-
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
por: Sobhani, Navid, et al.
Publicado: (2018) -
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
por: Tierno, Domenico, et al.
Publicado: (2023) -
A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection
por: Bortul, Marina, et al.
Publicado: (2023) -
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer
por: Alborelli, Ilaria, et al.
Publicado: (2019) -
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer
por: Tierno, Domenico, et al.
Publicado: (2023)